The different inhibitory effects of Huang-Lian-Jie-Du-Tang on cyclooxygenase 2 and 5-lipoxygenase
Huang-Lian-Jie-Du-Tang (HLJDT), a famous traditional Chinese prescription with wide anti-inflammatory applications, is an aqueous extract of four herbal materials: Rhizoma coptidis, Radix scutellariae, Cortex phellodendri, and Fructus gardeniae. Its effects on the cyclooxygenase (COX)-2 and 5-lipoxy...
Gespeichert in:
Veröffentlicht in: | Journal of ethnopharmacology 2012-09, Vol.143 (2), p.732-739 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 739 |
---|---|
container_issue | 2 |
container_start_page | 732 |
container_title | Journal of ethnopharmacology |
container_volume | 143 |
creator | Li, Li Zeng, Huawu Shan, Lei Yuan, Xin Li, Yushan Liu, Runhui Zhang, Weidong |
description | Huang-Lian-Jie-Du-Tang (HLJDT), a famous traditional Chinese prescription with wide anti-inflammatory applications, is an aqueous extract of four herbal materials: Rhizoma coptidis, Radix scutellariae, Cortex phellodendri, and Fructus gardeniae. Its effects on the cyclooxygenase (COX)-2 and 5-lipoxygenase (5-LOX) pathways are thought to be responsible for its anti-inflammatory activity. However, our previous work found that the inhibitory effects of HLJDT act on the 5-LOX pathway but not on the COX pathway. The possibility that HLJDT inhibits COX-2- or 5-LOX-catalyzed eicosanoid generation by downregulating enzyme expression requires further investigation.
To observe the effects of HLJDT and its four major components (baicalin, baicalein, berberine and geniposide) on COX-2- or 5-LOX-catalyzed eicosanoid generation and to distinguish the effects of HLJDT on enzyme activity from those on enzyme expression.
The topical anti-inflammatory activities and inhibition of eicosanoid formation of HLJDT and its components were observed in an arachidonic acid (AA)-induced mouse ear edema model. Macrophage-based systems were established to observe the effects of the drugs on enzyme activity and enzyme expression of COX-2 and 5-LOX. Further experiments were carried out to confirm these effects at the mRNA and protein levels.
Topical treatment of HLJDT significantly inhibited AA-induced mouse ear edema and reduced PGE2 and LTB4 release in the edematous ears. Baicalein, geniposide, and berberine also ameliorated the symptoms and suppressed eicosanoid generation with varying efficacies. Cell-based assays showed that HLJDT and baicalein inhibited the PGE2 levels by decreasing COX-2 enzyme expression without affecting COX-2 enzyme activity in RAW 246.7 murine macrophages. The other experiments on rat peritoneal macrophages indicated that HLJDT and baicalein exerted significant inhibition on LTB4 production by decreasing 5-LOX enzyme activity. The real-time PCR and western blotting data demonstrated that HLJDT and baicalein reduced COX-2 expression at the mRNA and protein levels, whereas no inhibition on 5-LOX expression was observed.
HLJDT can suppress eicosanoid generation via both the COX and LOX pathways, which definitely contributes to its topical anti-inflammatory activity. We have confirmed that its dual inhibition on the COX and LOX pathways mainly result from the downregulation of COX-2 expression and direct inhibition of 5-LOX activity, respectively. Baicalein worked |
doi_str_mv | 10.1016/j.jep.2012.07.037 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1039037948</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S037887411200517X</els_id><sourcerecordid>1039037948</sourcerecordid><originalsourceid>FETCH-LOGICAL-c443t-e10d64f92380110d8e4f6694beca87b47a5b41ce18bd7b4443e7bc74e89d20203</originalsourceid><addsrcrecordid>eNp9kMFuGyEURVHUKHHdfkA3LctumAKDB0ZdVWnStLLURZ01Ypg3DtYYXJiJ6r_Pi5xk2RVwde7T4xDyQfBKcNF82VU7OFSSC1lxXfFan5GFMFoyvdL1G7LAxDCjlbgkb0vZcc61UPyCXEppjDJNuyBucw-0D8MAGeJEQ7wPXZhSPlLAzE-FpoHezi5u2Tq4yH4FYN9ntsGApkj90Y8p_TtuIboCVFIXe7piYzi8hu_I-eDGAu-fzyW5u7neXN2y9e8fP6--rZlXqp4YCN43amhlbbjAuwE1NE2rOvDO6E5pt-qU8CBM1-MTO6A7rxWYtpdc8npJPp_mHnL6O0OZ7D4UD-PoIqS5WMHrFoW0yiAqTqjPqZQMgz3ksHf5iJB9Mmt3Fs3aJ7OWa4s17Hx8Hj93e-hfGy8qEfh0AgaXrNvmUOzdH5ygULvSBj-2JF9PBKCGhwDZFh8geuhDRtW2T-E_CzwCIsqRwQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1039037948</pqid></control><display><type>article</type><title>The different inhibitory effects of Huang-Lian-Jie-Du-Tang on cyclooxygenase 2 and 5-lipoxygenase</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Li, Li ; Zeng, Huawu ; Shan, Lei ; Yuan, Xin ; Li, Yushan ; Liu, Runhui ; Zhang, Weidong</creator><creatorcontrib>Li, Li ; Zeng, Huawu ; Shan, Lei ; Yuan, Xin ; Li, Yushan ; Liu, Runhui ; Zhang, Weidong</creatorcontrib><description>Huang-Lian-Jie-Du-Tang (HLJDT), a famous traditional Chinese prescription with wide anti-inflammatory applications, is an aqueous extract of four herbal materials: Rhizoma coptidis, Radix scutellariae, Cortex phellodendri, and Fructus gardeniae. Its effects on the cyclooxygenase (COX)-2 and 5-lipoxygenase (5-LOX) pathways are thought to be responsible for its anti-inflammatory activity. However, our previous work found that the inhibitory effects of HLJDT act on the 5-LOX pathway but not on the COX pathway. The possibility that HLJDT inhibits COX-2- or 5-LOX-catalyzed eicosanoid generation by downregulating enzyme expression requires further investigation.
To observe the effects of HLJDT and its four major components (baicalin, baicalein, berberine and geniposide) on COX-2- or 5-LOX-catalyzed eicosanoid generation and to distinguish the effects of HLJDT on enzyme activity from those on enzyme expression.
The topical anti-inflammatory activities and inhibition of eicosanoid formation of HLJDT and its components were observed in an arachidonic acid (AA)-induced mouse ear edema model. Macrophage-based systems were established to observe the effects of the drugs on enzyme activity and enzyme expression of COX-2 and 5-LOX. Further experiments were carried out to confirm these effects at the mRNA and protein levels.
Topical treatment of HLJDT significantly inhibited AA-induced mouse ear edema and reduced PGE2 and LTB4 release in the edematous ears. Baicalein, geniposide, and berberine also ameliorated the symptoms and suppressed eicosanoid generation with varying efficacies. Cell-based assays showed that HLJDT and baicalein inhibited the PGE2 levels by decreasing COX-2 enzyme expression without affecting COX-2 enzyme activity in RAW 246.7 murine macrophages. The other experiments on rat peritoneal macrophages indicated that HLJDT and baicalein exerted significant inhibition on LTB4 production by decreasing 5-LOX enzyme activity. The real-time PCR and western blotting data demonstrated that HLJDT and baicalein reduced COX-2 expression at the mRNA and protein levels, whereas no inhibition on 5-LOX expression was observed.
HLJDT can suppress eicosanoid generation via both the COX and LOX pathways, which definitely contributes to its topical anti-inflammatory activity. We have confirmed that its dual inhibition on the COX and LOX pathways mainly result from the downregulation of COX-2 expression and direct inhibition of 5-LOX activity, respectively. Baicalein worked as a potent active component in most of the tests. These findings about the different inhibitory effects of HLJDT on COX-2 and 5-LOX help to better understand the mechanism of HLJDT and promote safer applications of drug.
[Display omitted]</description><identifier>ISSN: 0378-8741</identifier><identifier>EISSN: 1872-7573</identifier><identifier>DOI: 10.1016/j.jep.2012.07.037</identifier><identifier>PMID: 22884869</identifier><language>eng</language><publisher>Ireland: Elsevier Ireland Ltd</publisher><subject>5-lipoxygenase ; Animals ; anti-inflammatory activity ; Anti-Inflammatory Agents, Non-Steroidal - pharmacology ; Anti-Inflammatory Agents, Non-Steroidal - therapeutic use ; Arachidonate 5-Lipoxygenase - genetics ; Arachidonate 5-Lipoxygenase - metabolism ; Arachidonic Acid ; Baicalein ; Berberine - pharmacology ; Berberine - therapeutic use ; Cell Line ; Cyclooxygenase 2 - genetics ; Cyclooxygenase 2 - metabolism ; Cyclooxygenase 2 Inhibitors - pharmacology ; Cyclooxygenase 2 Inhibitors - therapeutic use ; Cyclooxygenase-2 ; Dinoprostone - metabolism ; drugs ; Drugs, Chinese Herbal - pharmacology ; Drugs, Chinese Herbal - therapeutic use ; ears ; edema ; Edema - chemically induced ; Edema - drug therapy ; Edema - metabolism ; Enzyme activity ; Enzyme expression ; Flavanones - pharmacology ; Flavanones - therapeutic use ; Flavonoids - pharmacology ; Flavonoids - therapeutic use ; gene expression ; Huang-Lian-Jie-Du-Tang ; Iridoids - pharmacology ; Iridoids - therapeutic use ; Leukotriene B4 ; Leukotriene B4 - metabolism ; Lipoxygenase Inhibitors - pharmacology ; Lipoxygenase Inhibitors - therapeutic use ; macrophages ; Male ; messenger RNA ; Mice ; Mice, Inbred ICR ; Mouse ear edema ; Prostaglandin E2 ; prostaglandin synthase ; quantitative polymerase chain reaction ; Rats ; Rats, Sprague-Dawley ; RNA, Messenger - metabolism ; Western blotting</subject><ispartof>Journal of ethnopharmacology, 2012-09, Vol.143 (2), p.732-739</ispartof><rights>2012 Elsevier Ireland Ltd</rights><rights>Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c443t-e10d64f92380110d8e4f6694beca87b47a5b41ce18bd7b4443e7bc74e89d20203</citedby><cites>FETCH-LOGICAL-c443t-e10d64f92380110d8e4f6694beca87b47a5b41ce18bd7b4443e7bc74e89d20203</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jep.2012.07.037$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22884869$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Li, Li</creatorcontrib><creatorcontrib>Zeng, Huawu</creatorcontrib><creatorcontrib>Shan, Lei</creatorcontrib><creatorcontrib>Yuan, Xin</creatorcontrib><creatorcontrib>Li, Yushan</creatorcontrib><creatorcontrib>Liu, Runhui</creatorcontrib><creatorcontrib>Zhang, Weidong</creatorcontrib><title>The different inhibitory effects of Huang-Lian-Jie-Du-Tang on cyclooxygenase 2 and 5-lipoxygenase</title><title>Journal of ethnopharmacology</title><addtitle>J Ethnopharmacol</addtitle><description>Huang-Lian-Jie-Du-Tang (HLJDT), a famous traditional Chinese prescription with wide anti-inflammatory applications, is an aqueous extract of four herbal materials: Rhizoma coptidis, Radix scutellariae, Cortex phellodendri, and Fructus gardeniae. Its effects on the cyclooxygenase (COX)-2 and 5-lipoxygenase (5-LOX) pathways are thought to be responsible for its anti-inflammatory activity. However, our previous work found that the inhibitory effects of HLJDT act on the 5-LOX pathway but not on the COX pathway. The possibility that HLJDT inhibits COX-2- or 5-LOX-catalyzed eicosanoid generation by downregulating enzyme expression requires further investigation.
To observe the effects of HLJDT and its four major components (baicalin, baicalein, berberine and geniposide) on COX-2- or 5-LOX-catalyzed eicosanoid generation and to distinguish the effects of HLJDT on enzyme activity from those on enzyme expression.
The topical anti-inflammatory activities and inhibition of eicosanoid formation of HLJDT and its components were observed in an arachidonic acid (AA)-induced mouse ear edema model. Macrophage-based systems were established to observe the effects of the drugs on enzyme activity and enzyme expression of COX-2 and 5-LOX. Further experiments were carried out to confirm these effects at the mRNA and protein levels.
Topical treatment of HLJDT significantly inhibited AA-induced mouse ear edema and reduced PGE2 and LTB4 release in the edematous ears. Baicalein, geniposide, and berberine also ameliorated the symptoms and suppressed eicosanoid generation with varying efficacies. Cell-based assays showed that HLJDT and baicalein inhibited the PGE2 levels by decreasing COX-2 enzyme expression without affecting COX-2 enzyme activity in RAW 246.7 murine macrophages. The other experiments on rat peritoneal macrophages indicated that HLJDT and baicalein exerted significant inhibition on LTB4 production by decreasing 5-LOX enzyme activity. The real-time PCR and western blotting data demonstrated that HLJDT and baicalein reduced COX-2 expression at the mRNA and protein levels, whereas no inhibition on 5-LOX expression was observed.
HLJDT can suppress eicosanoid generation via both the COX and LOX pathways, which definitely contributes to its topical anti-inflammatory activity. We have confirmed that its dual inhibition on the COX and LOX pathways mainly result from the downregulation of COX-2 expression and direct inhibition of 5-LOX activity, respectively. Baicalein worked as a potent active component in most of the tests. These findings about the different inhibitory effects of HLJDT on COX-2 and 5-LOX help to better understand the mechanism of HLJDT and promote safer applications of drug.
[Display omitted]</description><subject>5-lipoxygenase</subject><subject>Animals</subject><subject>anti-inflammatory activity</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - pharmacology</subject><subject>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</subject><subject>Arachidonate 5-Lipoxygenase - genetics</subject><subject>Arachidonate 5-Lipoxygenase - metabolism</subject><subject>Arachidonic Acid</subject><subject>Baicalein</subject><subject>Berberine - pharmacology</subject><subject>Berberine - therapeutic use</subject><subject>Cell Line</subject><subject>Cyclooxygenase 2 - genetics</subject><subject>Cyclooxygenase 2 - metabolism</subject><subject>Cyclooxygenase 2 Inhibitors - pharmacology</subject><subject>Cyclooxygenase 2 Inhibitors - therapeutic use</subject><subject>Cyclooxygenase-2</subject><subject>Dinoprostone - metabolism</subject><subject>drugs</subject><subject>Drugs, Chinese Herbal - pharmacology</subject><subject>Drugs, Chinese Herbal - therapeutic use</subject><subject>ears</subject><subject>edema</subject><subject>Edema - chemically induced</subject><subject>Edema - drug therapy</subject><subject>Edema - metabolism</subject><subject>Enzyme activity</subject><subject>Enzyme expression</subject><subject>Flavanones - pharmacology</subject><subject>Flavanones - therapeutic use</subject><subject>Flavonoids - pharmacology</subject><subject>Flavonoids - therapeutic use</subject><subject>gene expression</subject><subject>Huang-Lian-Jie-Du-Tang</subject><subject>Iridoids - pharmacology</subject><subject>Iridoids - therapeutic use</subject><subject>Leukotriene B4</subject><subject>Leukotriene B4 - metabolism</subject><subject>Lipoxygenase Inhibitors - pharmacology</subject><subject>Lipoxygenase Inhibitors - therapeutic use</subject><subject>macrophages</subject><subject>Male</subject><subject>messenger RNA</subject><subject>Mice</subject><subject>Mice, Inbred ICR</subject><subject>Mouse ear edema</subject><subject>Prostaglandin E2</subject><subject>prostaglandin synthase</subject><subject>quantitative polymerase chain reaction</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>RNA, Messenger - metabolism</subject><subject>Western blotting</subject><issn>0378-8741</issn><issn>1872-7573</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMFuGyEURVHUKHHdfkA3LctumAKDB0ZdVWnStLLURZ01Ypg3DtYYXJiJ6r_Pi5xk2RVwde7T4xDyQfBKcNF82VU7OFSSC1lxXfFan5GFMFoyvdL1G7LAxDCjlbgkb0vZcc61UPyCXEppjDJNuyBucw-0D8MAGeJEQ7wPXZhSPlLAzE-FpoHezi5u2Tq4yH4FYN9ntsGApkj90Y8p_TtuIboCVFIXe7piYzi8hu_I-eDGAu-fzyW5u7neXN2y9e8fP6--rZlXqp4YCN43amhlbbjAuwE1NE2rOvDO6E5pt-qU8CBM1-MTO6A7rxWYtpdc8npJPp_mHnL6O0OZ7D4UD-PoIqS5WMHrFoW0yiAqTqjPqZQMgz3ksHf5iJB9Mmt3Fs3aJ7OWa4s17Hx8Hj93e-hfGy8qEfh0AgaXrNvmUOzdH5ygULvSBj-2JF9PBKCGhwDZFh8geuhDRtW2T-E_CzwCIsqRwQ</recordid><startdate>20120928</startdate><enddate>20120928</enddate><creator>Li, Li</creator><creator>Zeng, Huawu</creator><creator>Shan, Lei</creator><creator>Yuan, Xin</creator><creator>Li, Yushan</creator><creator>Liu, Runhui</creator><creator>Zhang, Weidong</creator><general>Elsevier Ireland Ltd</general><scope>FBQ</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20120928</creationdate><title>The different inhibitory effects of Huang-Lian-Jie-Du-Tang on cyclooxygenase 2 and 5-lipoxygenase</title><author>Li, Li ; Zeng, Huawu ; Shan, Lei ; Yuan, Xin ; Li, Yushan ; Liu, Runhui ; Zhang, Weidong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c443t-e10d64f92380110d8e4f6694beca87b47a5b41ce18bd7b4443e7bc74e89d20203</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>5-lipoxygenase</topic><topic>Animals</topic><topic>anti-inflammatory activity</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - pharmacology</topic><topic>Anti-Inflammatory Agents, Non-Steroidal - therapeutic use</topic><topic>Arachidonate 5-Lipoxygenase - genetics</topic><topic>Arachidonate 5-Lipoxygenase - metabolism</topic><topic>Arachidonic Acid</topic><topic>Baicalein</topic><topic>Berberine - pharmacology</topic><topic>Berberine - therapeutic use</topic><topic>Cell Line</topic><topic>Cyclooxygenase 2 - genetics</topic><topic>Cyclooxygenase 2 - metabolism</topic><topic>Cyclooxygenase 2 Inhibitors - pharmacology</topic><topic>Cyclooxygenase 2 Inhibitors - therapeutic use</topic><topic>Cyclooxygenase-2</topic><topic>Dinoprostone - metabolism</topic><topic>drugs</topic><topic>Drugs, Chinese Herbal - pharmacology</topic><topic>Drugs, Chinese Herbal - therapeutic use</topic><topic>ears</topic><topic>edema</topic><topic>Edema - chemically induced</topic><topic>Edema - drug therapy</topic><topic>Edema - metabolism</topic><topic>Enzyme activity</topic><topic>Enzyme expression</topic><topic>Flavanones - pharmacology</topic><topic>Flavanones - therapeutic use</topic><topic>Flavonoids - pharmacology</topic><topic>Flavonoids - therapeutic use</topic><topic>gene expression</topic><topic>Huang-Lian-Jie-Du-Tang</topic><topic>Iridoids - pharmacology</topic><topic>Iridoids - therapeutic use</topic><topic>Leukotriene B4</topic><topic>Leukotriene B4 - metabolism</topic><topic>Lipoxygenase Inhibitors - pharmacology</topic><topic>Lipoxygenase Inhibitors - therapeutic use</topic><topic>macrophages</topic><topic>Male</topic><topic>messenger RNA</topic><topic>Mice</topic><topic>Mice, Inbred ICR</topic><topic>Mouse ear edema</topic><topic>Prostaglandin E2</topic><topic>prostaglandin synthase</topic><topic>quantitative polymerase chain reaction</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>RNA, Messenger - metabolism</topic><topic>Western blotting</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Li</creatorcontrib><creatorcontrib>Zeng, Huawu</creatorcontrib><creatorcontrib>Shan, Lei</creatorcontrib><creatorcontrib>Yuan, Xin</creatorcontrib><creatorcontrib>Li, Yushan</creatorcontrib><creatorcontrib>Liu, Runhui</creatorcontrib><creatorcontrib>Zhang, Weidong</creatorcontrib><collection>AGRIS</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of ethnopharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Li</au><au>Zeng, Huawu</au><au>Shan, Lei</au><au>Yuan, Xin</au><au>Li, Yushan</au><au>Liu, Runhui</au><au>Zhang, Weidong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The different inhibitory effects of Huang-Lian-Jie-Du-Tang on cyclooxygenase 2 and 5-lipoxygenase</atitle><jtitle>Journal of ethnopharmacology</jtitle><addtitle>J Ethnopharmacol</addtitle><date>2012-09-28</date><risdate>2012</risdate><volume>143</volume><issue>2</issue><spage>732</spage><epage>739</epage><pages>732-739</pages><issn>0378-8741</issn><eissn>1872-7573</eissn><abstract>Huang-Lian-Jie-Du-Tang (HLJDT), a famous traditional Chinese prescription with wide anti-inflammatory applications, is an aqueous extract of four herbal materials: Rhizoma coptidis, Radix scutellariae, Cortex phellodendri, and Fructus gardeniae. Its effects on the cyclooxygenase (COX)-2 and 5-lipoxygenase (5-LOX) pathways are thought to be responsible for its anti-inflammatory activity. However, our previous work found that the inhibitory effects of HLJDT act on the 5-LOX pathway but not on the COX pathway. The possibility that HLJDT inhibits COX-2- or 5-LOX-catalyzed eicosanoid generation by downregulating enzyme expression requires further investigation.
To observe the effects of HLJDT and its four major components (baicalin, baicalein, berberine and geniposide) on COX-2- or 5-LOX-catalyzed eicosanoid generation and to distinguish the effects of HLJDT on enzyme activity from those on enzyme expression.
The topical anti-inflammatory activities and inhibition of eicosanoid formation of HLJDT and its components were observed in an arachidonic acid (AA)-induced mouse ear edema model. Macrophage-based systems were established to observe the effects of the drugs on enzyme activity and enzyme expression of COX-2 and 5-LOX. Further experiments were carried out to confirm these effects at the mRNA and protein levels.
Topical treatment of HLJDT significantly inhibited AA-induced mouse ear edema and reduced PGE2 and LTB4 release in the edematous ears. Baicalein, geniposide, and berberine also ameliorated the symptoms and suppressed eicosanoid generation with varying efficacies. Cell-based assays showed that HLJDT and baicalein inhibited the PGE2 levels by decreasing COX-2 enzyme expression without affecting COX-2 enzyme activity in RAW 246.7 murine macrophages. The other experiments on rat peritoneal macrophages indicated that HLJDT and baicalein exerted significant inhibition on LTB4 production by decreasing 5-LOX enzyme activity. The real-time PCR and western blotting data demonstrated that HLJDT and baicalein reduced COX-2 expression at the mRNA and protein levels, whereas no inhibition on 5-LOX expression was observed.
HLJDT can suppress eicosanoid generation via both the COX and LOX pathways, which definitely contributes to its topical anti-inflammatory activity. We have confirmed that its dual inhibition on the COX and LOX pathways mainly result from the downregulation of COX-2 expression and direct inhibition of 5-LOX activity, respectively. Baicalein worked as a potent active component in most of the tests. These findings about the different inhibitory effects of HLJDT on COX-2 and 5-LOX help to better understand the mechanism of HLJDT and promote safer applications of drug.
[Display omitted]</abstract><cop>Ireland</cop><pub>Elsevier Ireland Ltd</pub><pmid>22884869</pmid><doi>10.1016/j.jep.2012.07.037</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0378-8741 |
ispartof | Journal of ethnopharmacology, 2012-09, Vol.143 (2), p.732-739 |
issn | 0378-8741 1872-7573 |
language | eng |
recordid | cdi_proquest_miscellaneous_1039037948 |
source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
subjects | 5-lipoxygenase Animals anti-inflammatory activity Anti-Inflammatory Agents, Non-Steroidal - pharmacology Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Arachidonate 5-Lipoxygenase - genetics Arachidonate 5-Lipoxygenase - metabolism Arachidonic Acid Baicalein Berberine - pharmacology Berberine - therapeutic use Cell Line Cyclooxygenase 2 - genetics Cyclooxygenase 2 - metabolism Cyclooxygenase 2 Inhibitors - pharmacology Cyclooxygenase 2 Inhibitors - therapeutic use Cyclooxygenase-2 Dinoprostone - metabolism drugs Drugs, Chinese Herbal - pharmacology Drugs, Chinese Herbal - therapeutic use ears edema Edema - chemically induced Edema - drug therapy Edema - metabolism Enzyme activity Enzyme expression Flavanones - pharmacology Flavanones - therapeutic use Flavonoids - pharmacology Flavonoids - therapeutic use gene expression Huang-Lian-Jie-Du-Tang Iridoids - pharmacology Iridoids - therapeutic use Leukotriene B4 Leukotriene B4 - metabolism Lipoxygenase Inhibitors - pharmacology Lipoxygenase Inhibitors - therapeutic use macrophages Male messenger RNA Mice Mice, Inbred ICR Mouse ear edema Prostaglandin E2 prostaglandin synthase quantitative polymerase chain reaction Rats Rats, Sprague-Dawley RNA, Messenger - metabolism Western blotting |
title | The different inhibitory effects of Huang-Lian-Jie-Du-Tang on cyclooxygenase 2 and 5-lipoxygenase |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T04%3A53%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20different%20inhibitory%20effects%20of%20Huang-Lian-Jie-Du-Tang%20on%20cyclooxygenase%202%20and%205-lipoxygenase&rft.jtitle=Journal%20of%20ethnopharmacology&rft.au=Li,%20Li&rft.date=2012-09-28&rft.volume=143&rft.issue=2&rft.spage=732&rft.epage=739&rft.pages=732-739&rft.issn=0378-8741&rft.eissn=1872-7573&rft_id=info:doi/10.1016/j.jep.2012.07.037&rft_dat=%3Cproquest_cross%3E1039037948%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1039037948&rft_id=info:pmid/22884869&rft_els_id=S037887411200517X&rfr_iscdi=true |